New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft‐versus‐host disease - Lutz - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
Mechanisms of resistance to mTOR inhibitors - ScienceDirect
mTOR in inflammatory skin diseases: Review of the literature and our experience
The Evolving Role of mTOR Inhibition in Transplantation Tolerance | American Society of Nephrology
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
Newly Approved mTOR Inhibitors for the Treatment of Metastatic Renal Cell Carcinoma
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Targeting mTOR for cancer therapy | Journal of Hematology & Oncology | Full Text
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
mTOR inhibitors in cancer therapy | F1000Research
Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram
Potential mechanisms of action of sirolimus and metformin. Sirolimus... | Download Scientific Diagram
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review - Gynecologic Oncology
mTOR inhibitors - Wikipedia
Rapamycin: One Drug, Many Effects - ScienceDirect
Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation | SpringerLink
The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials - ScienceDirect
Current development of mTOR inhibitors as anticancer agents | Nature Reviews Drug Discovery
The Pharmacology of mTOR Inhibition
Frontiers | Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor | Pharmacology
Immunoregulatory functions of mTOR inhibition | Nature Reviews Immunology
Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen
mTOR inhibitors and diabetes - ScienceDirect
